Derner School of Psychology, Adelphi University, Garden City, New York, USA.
Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Clin Psychol Psychother. 2022 Nov;29(6):1905-1917. doi: 10.1002/cpp.2759. Epub 2022 Jun 20.
Based on the results of prior research, we examined relationships between Personality Assessment Inventory (PAI) items on clinical scales of antisocial features (ANT) and anxiety-related disorders (ARD) with patient- and therapist-rated alliance early in treatment (third or fourth session). We also explored the relationship between the PAI treatment rejection scale (RXR) and early session therapist-rated alliance, despite null findings in previous work. We used PAI protocols from a clinical outpatient sample (N = 80). Data were analysed using backwards linear regressions. Results indicated that a group of ANT items from different ANT subscales predicted patient-rated therapeutic alliance, F(8,59) = 5.182, p = .000, R of .413, f = 0.70. Additionally, a group of ARD items from different ARD subscales significantly predicted therapist-rated alliance, F(6,62) = 3.007, p = .012, R of .225, f = 0.29. No significant relationships were found for RXR items and therapist-rated alliance, consistent with prior findings. Clinical implications are discussed.
基于先前研究的结果，我们考察了人格评估量表（PAI）中临床反社会特征（ANT）和焦虑相关障碍（ARD）量表项目与治疗早期（第三或第四次治疗）患者和治疗师评定的联盟之间的关系。我们还探讨了 PAI 治疗拒绝量表（RXR）与早期治疗师评定联盟之间的关系，尽管先前的研究工作未发现任何关联。我们使用了来自临床门诊样本的 PAI 协议（N=80）。数据分析采用向后线性回归。结果表明，来自不同 ANT 亚量表的一组 ANT 项目预测了患者评定的治疗联盟，F（8,59）=5.182，p=0.000，R 为.413，f 为 0.70。此外，来自不同 ARD 亚量表的一组 ARD 项目显著预测了治疗师评定的联盟，F（6,62）=3.007，p=0.012，R 为.225，f 为 0.29。与先前的研究结果一致，RXR 项目与治疗师评定的联盟之间没有显著关系。讨论了临床意义。
